Altre lingue Aquaporin A/S

Azioni

Mercato chiuso - Nasdaq Copenhagen Altri mercati azionari 17:20:00 12/07/2024			Variaz. 5gg	Var. 1 gen.
20,8 ^DKK	-1,42%		+6,12%	-54,78%

11/07	Aquaporin riceve un ordine per prodotti di trattamento dell'acqua	MT
29/05	Aquaporin si espande in Cina con il lancio di nuovi prodotti	CI

Aquaporin Lands Order for Water Treatment Products	11/07
Aquaporin secures order with large EMEA water treatment company	11/07
Aquaporin Expands in China: Launching New Products	29/05
Aquaporin Expands in China with Launching New Products	29/05
Aquaporin Q1 2024 Trading Statement - maintains guidance with strong orderbook	23/05
Aquaporin A/S : Major shareholder announcement	03/05
Business transacted at the annual general meeting of Aquaporin A/S	29/04
Major shareholder announcement	25/04
Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them in Aquaporin's shares	25/04
Aquaporin raises DKK 172 million	25/04
Notice convening the annual general meeting 2024	05/04
Aquaporin publishes prospectus and initiates rights issue	05/04
Aquaporin A/S Reports Earnings Results for the Full Year Ended December 31, 2023	05/04
Aquaporin announces full-year 2023 results, with year-on-year revenue growth of 95%	05/04
Aquaporin A/S Provides Earnings Guidance for the Year 2024	05/04
London Stocks Retreat Ahead of Final UK GDP Data for Q4 2023	25/03
AstraZeneca Says Ultomiris Gets US FDA Approval to Treat Neuromyelitis Optica Spectrum Disorder	25/03
AstraZeneca Bags US FDA Clearance for Rare Autoimmune Disease Treatment Ultomiris	25/03
AstraZeneca Receives US Approval for Neuromyelitis Optica Spectrum Disorder Treatment	25/03
Business transacted at the extraordinary general meeting of Aquaporin A/S	22/03

Non ci sono risultati per questa ricerca